Skip to main content

Find Clinical Trials

Home
Conditions
Pseudomyxoma Peritonei

Clinical trial condition

Pseudomyxoma Peritonei

Explore clinical trials studying Pseudomyxoma Peritonei. Study availability and eligibility vary by location and protocol.

27 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Pseudomyxoma Peritonei trial results

Recruiting

Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients

NCT06800391

Conditions: Adenocarcinoma, Adenocarcinoma, Mucinous, Carcinoma, +5 more
Locations: Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy

View Trial Details

Recruiting

Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies

NCT02073500

Conditions: Abdominal Neoplasms, Adenocarcinoma, Adenocarcinoma, Mucinous, +36 more
Locations: The Norwegian Radium Hospital Oslo, Norway

View Trial Details

Not yet recruiting

Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)

NCT06084780

Conditions: Adenocarcinoma, Adenocarcinoma, Mucinous, Carcinoma, +7 more
Locations: Cleveland Clinic Digestive Disease & Surgery Institute (DDSI), Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Not yet recruiting

Proactive Temperature Management in CRS-HIPEC for Prevention of Delirium

NCT07378371

Conditions: Adenocarcinoma, Adenocarcinoma, Mucinous, Carcinoma, +18 more
Locations: Aerospace Center Hospital Beijing, China

View Trial Details

Active, not recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions: Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

View all 1007 locations

View Trial Details

Active, not recruiting

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

NCT02387203

Conditions: Adenocarcinoma, Adenocarcinoma, Mucinous, Appendiceal Neoplasms, +15 more
Locations: Mercy Medical Center Baltimore, Maryland, United States

View Trial Details

Completed

Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei

NCT06839378

Conditions: Adenocarcinoma, Adenocarcinoma, Mucinous, Carcinoma, +5 more
Locations: Beijing Tsinghua Changgung Hospital Beijing, China

View Trial Details

Completed

HIPEC for Peritoneal Carcinomatosis

NCT02040142

Conditions: Abdominal Neoplasms, Adenocarcinoma, Adenocarcinoma, Mucinous, +28 more
Locations: Department of Surgery, Montefiore Medical Center- Weiler Division The Bronx, New York, United States

View Trial Details

Completed

Severe Neutropenia After HIPEC Using Mitomycin-C

NCT05513183

Conditions: Adenocarcinoma, Adenocarcinoma, Mucinous, Appendiceal Neoplasm, +18 more
Locations: Division of Colon and Rectal Surgery, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea Seoul, South Korea

View Trial Details

Completed

Phase I Trial HIPEC With Nal-irinotecan

NCT04088786

Conditions: Adenocarcinoma, Adenocarcinoma, Mucinous, Adenoma, +26 more
Locations: University of Kentucky Lexington, Kentucky, United States

Stony Brook University Cancer Center Stony Brook, New York, United States

View Trial Details